Source comparison
Application Contexts: Surface Repair vs Deep Tissue Healing
GHK-Cu demonstrates superior efficacy in research models involving epidermal and superficial dermal injury. A 2018 randomized controlled study published in Dermatologic Surgery found that topical GHK-Cu application post-laser resurfacing reduced erythema durat
This comparison does not assign a generated winner or score.
- GHK-Cu demonstrates superior efficacy in research models involving epidermal and superficial dermal injury. A 2018 randomized controlled study published in Dermatologic Surgery found that topical GHK-Cu application post-laser resurfacing reduced erythema duration by 42% and increased re-epithelialization rate by 31% compared to standard post-procedure care. The peptide's small molecular weight (340 Da as the copper complex) allows transdermal penetration when formulated at 1–2% concentration in appropriate carrier systems. Typically including penetration enhancers like dimethyl sulfoxide (DMSO) or liposomal encapsulation.
- TB-500 shows measurability stronger outcomes in models involving tendon, ligament, and muscle tissue damage where cell migration distances exceed 500 micrometers. Beyond the effective range of passive diffusion-based signaling. Equine studies (horses are the most extensively studied mammalian model for TB-500 due to tendon injury prevalence) demonstrated 68% faster return to functional load-bearing in induced flexor tendon injuries when TB-500 was administered subcutaneously at 2mg twice weekly for four weeks. The peptide's 4.9 kDa molecular weight prevents topical absorption. Systemic administration via subcutaneous or intramuscular injection is required for bioavailability.
- Our experience at Real Peptides guiding research institutions on peptide selection: dermatology and cosmetic research labs consistently request GHK-Cu for protocols involving photoaging, post-inflammatory hyperpigmentation, and wound healing with minimal scarring. Orthopedic and sports medicine researchers favor TB-500 for models studying ligament repair, post-surgical recovery, and ischemia-reperfusion injury where systemic circulation and cellular recruitment are the therapeutic targets.